These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22343225)

  • 1. Ovarian cancer: etiology, risk factors, and epidemiology.
    Hunn J; Rodriguez GC
    Clin Obstet Gynecol; 2012 Mar; 55(1):3-23. PubMed ID: 22343225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.
    Salehi F; Dunfield L; Phillips KP; Krewski D; Vanderhyden BC
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):301-21. PubMed ID: 18368558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ovarian cancer.
    Hanna L; Adams M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):339-62. PubMed ID: 16368271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
    King MC; Marks JH; Mandell JB;
    Science; 2003 Oct; 302(5645):643-6. PubMed ID: 14576434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of ovarian cancer development].
    Horiuchi A; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():597-600. PubMed ID: 15535315
    [No Abstract]   [Full Text] [Related]  

  • 10. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
    Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
    Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive issues for women with BRCA mutations.
    Friedman LC; Kramer RM
    J Natl Cancer Inst Monogr; 2005; (34):83-6. PubMed ID: 15784831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of ovarian cancer].
    Tamaya T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():435-40. PubMed ID: 15535283
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.
    Ness RB; Grisso JA; Cottreau C; Klapper J; Vergona R; Wheeler JE; Morgan M; Schlesselman JJ
    Epidemiology; 2000 Mar; 11(2):111-7. PubMed ID: 11021606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ovarian cancer: lesbian and heterosexual women.
    Dibble SL; Roberts SA; Robertson PA; Paul SM
    Oncol Nurs Forum; 2002; 29(1):E1-7. PubMed ID: 11845216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
    Gronwald J; Byrski T; Huzarski T; Cybulski C; Sun P; Tulman A; Narod SA; Lubinski J
    Breast Cancer Res Treat; 2006 Jan; 95(2):105-9. PubMed ID: 16261399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer: risks.
    Sueblinvong T; Carney ME
    Hawaii Med J; 2009 Mar; 68(2):40-6. PubMed ID: 19385377
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
    Lukanova A; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):98-107. PubMed ID: 15668482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.